A new liver cell has been identified, which may eradicate the need of liver transplant in the near future. As there is an alarming rise in need of a liver transplant, this cell could be a boon for thousands.
In a paper published today in Nature Communications, the scientists have identified a new type of cell called a hepatobiliary hybrid progenitor (HHyP), that forms during our early development in the womb. Surprisingly, HHyP also persist in small quantities in adults, and these cells can grow into the two main cell types of the adult liver (Hepatocytes and Cholangiocytes) giving HHyPs stem cell-like properties.
Living-donor Liver Transplant Offers Many Advantages Over Deceased Donor
Living-donor liver transplant (LDLT) may be a better option compared to deceased donor liver transplant (DDLT) with lesser complications and better survival of recipients and overall patient outcomes.
Advertisement
‘Liver disease is the fifth biggest killer in the UK, and the third most common cause of premature death and the number of cases is continuing to rise. However, the discovery new liver cell may revolutionize the medical world in a positive way.’
Read More..
Tweet it Now
Read More..
The team examined HHyPs and found that they resemble mouse stem cells which have been found to rapidly repair mice liver following major injuries, such as occurs in cirrhosis.
Lead author Dr. Tamir Rashid from the Centre for Stem Cells & Regenerative Medicine at King's College London said: "For the first time, we have found that cells with true stem cell-like properties may well exist in the human liver. This, in turn, could provide a wide range of regenerative medicine applications for treating liver disease, including the possibility of bypassing the need for liver transplants."
![Bio-artificial Liver, A Less-invasive, Long-Term Option For Acute Liver Failure]( "Bio-artificial Liver, A Less-invasive, Long-Term Option For Acute Liver Failure")
Spheroid Reservoir Bioartificial Liver device could allow physicians to treat and extend the lives of more patients cost-effectively, with fewer risks.
Liver disease is the fifth biggest killer in the UK* and the third most common cause of premature death and the number of cases is continuing to rise. It can be caused by lifestyle issues such as obesity, viruses, alcohol misuse or by non-lifestyle issues such as autoimmune and genetic mediated disease.
Symptoms of liver disease include jaundice, itching, and feelings of weakness and tiredness and in more severe cases, cirrhosis. The only treatment for severe liver diseases at present is a liver transplant which can lead to a lifetime of complications and for which the need for donor organs greatly outweighs the increasing demands.
"We now need to work quickly to unlock the recipe for converting pluripotent stem cells into HHyPs so that we could transplant those cells into patients at will. In the longer term, we will also be working to see if we can reprogramme HHyPs within the body using traditional pharmacological drugs to repair diseased livers without either cell or organ transplantation," said Dr. Rashid.
Source: Eurekalert
Bio-artificial Liver, A Less-invasive, Long-Term Option For Acute Liver Failure
Spheroid Reservoir Bioartificial Liver device could allow physicians to treat and extend the lives of more patients cost-effectively, with fewer risks.
Advertisement
Liver disease is the fifth biggest killer in the UK* and the third most common cause of premature death and the number of cases is continuing to rise. It can be caused by lifestyle issues such as obesity, viruses, alcohol misuse or by non-lifestyle issues such as autoimmune and genetic mediated disease.
Symptoms of liver disease include jaundice, itching, and feelings of weakness and tiredness and in more severe cases, cirrhosis. The only treatment for severe liver diseases at present is a liver transplant which can lead to a lifetime of complications and for which the need for donor organs greatly outweighs the increasing demands.
"We now need to work quickly to unlock the recipe for converting pluripotent stem cells into HHyPs so that we could transplant those cells into patients at will. In the longer term, we will also be working to see if we can reprogramme HHyPs within the body using traditional pharmacological drugs to repair diseased livers without either cell or organ transplantation," said Dr. Rashid.
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Organ Donation News
Research may speed the identification of patients who need liver transplants by analyzing blood samples to look for biomarkers associated with liver failure.
The discovery of T cells involvement in graft-versus-host disease is a vital step in finding more effective life-saving treatments for bone marrow transplant.
Donation after circulatory death (DCD) based heart transplantation based can increase hearts available for transplantation, contributing to the health-care systems.
Picking donor organs for transplant becomes an easy task with the help of new Artificial Intelligence (AI) technology.
The Indian Government is getting ready to develop 'one nation, one policy' for organ donation and transportation in the country to save lives.